These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 3383960)
1. Recent developments in prophylaxis and therapy of invasive fungal infections in granulocytopenic cancer patients. Meunier F; Klastersky J Eur J Cancer Clin Oncol; 1988 Mar; 24(3):539-44. PubMed ID: 3383960 [No Abstract] [Full Text] [Related]
2. Prophylaxis of fungal infections in neutropenic cancer patients. Meunier-Carpentier F Schweiz Med Wochenschr Suppl; 1983; 14():15-9. PubMed ID: 6318307 [TBL] [Abstract][Full Text] [Related]
3. Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients. Conneally E; Cafferkey MT; Daly PA; Keane CT; McCann SR Bone Marrow Transplant; 1990 Jun; 5(6):403-6. PubMed ID: 2196098 [TBL] [Abstract][Full Text] [Related]
4. Failure of amphotericin B spray to prevent aspergillosis in granulocytopenic patients. Jorgensen CJ; Dreyfus F; Vaixeler J; Guyomard S; Massiot C; Belanger C; Brunet F; Giraud T; Dupuis-Camay P Nouv Rev Fr Hematol (1978); 1989; 31(5):327-8. PubMed ID: 2587200 [TBL] [Abstract][Full Text] [Related]
5. [Fungal infections in children with malignant disease]. Michel G Arch Pediatr; 2011 May; 18 Suppl 1():S3-7. PubMed ID: 21596284 [TBL] [Abstract][Full Text] [Related]
6. Prevention of invasive fungal infections in patients with neoplastic disease. Walsh TJ; Lee JW Clin Infect Dis; 1993 Nov; 17 Suppl 2():S468-80. PubMed ID: 8274613 [TBL] [Abstract][Full Text] [Related]
7. Amphotericin B nasal spray as prophylaxis against aspergillosis in patients with neutropenia. Meunier-Carpentier F; Snoeck R; Gerain J; Muller C; Klastersky J N Engl J Med; 1984 Oct; 311(16):1056. PubMed ID: 6482917 [No Abstract] [Full Text] [Related]
8. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. Lopez-Berestein G; Fainstein V; Hopfer R; Mehta K; Sullivan MP; Keating M; Rosenblum MG; Mehta R; Luna M; Hersh EM J Infect Dis; 1985 Apr; 151(4):704-10. PubMed ID: 3973417 [TBL] [Abstract][Full Text] [Related]
9. Prophylaxis of Candida albicans infection in neutropenic mice with liposome-encapsulated amphotericin B. Lopez-Berestein G; Hopfer RL; Mehta R; Mehta K; Hersh EM; Juliano RL Antimicrob Agents Chemother; 1984 Mar; 25(3):366-7. PubMed ID: 6721469 [TBL] [Abstract][Full Text] [Related]
10. Tolerance and efficacy of Amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients. Erjavec Z; Woolthuis GM; de Vries-Hospers HG; Sluiter WJ; Daenen SM; de Pauw B; Halie MR Eur J Clin Microbiol Infect Dis; 1997 May; 16(5):364-8. PubMed ID: 9228476 [TBL] [Abstract][Full Text] [Related]
11. Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis. Walsh TJ; Aoki S; Mechinaud F; Bacher J; Lee J; Rubin M; Pizzo PA J Infect Dis; 1990 Apr; 161(4):755-60. PubMed ID: 2138654 [TBL] [Abstract][Full Text] [Related]
12. Empiric therapy with amphotericin B in febrile granulocytopenic patients. Walsh TJ; Lee J; Lecciones J; Rubin M; Butler K; Francis P; Weinberger M; Roilides E; Marshall D; Gress J Rev Infect Dis; 1991; 13(3):496-503. PubMed ID: 1866556 [TBL] [Abstract][Full Text] [Related]
13. Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis. Reichenspurner H; Gamberg P; Nitschke M; Valantine H; Hunt S; Oyer PE; Reitz BA Transplant Proc; 1997; 29(1-2):627-8. PubMed ID: 9123449 [No Abstract] [Full Text] [Related]
14. Experimental basis for use of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts. Walsh TJ; Lee J; Aoki S; Mechinaud F; Bacher J; Lecciones J; Thomas V; Rubin M; Pizzo PA Rev Infect Dis; 1990; 12 Suppl 3():S307-17. PubMed ID: 2184509 [TBL] [Abstract][Full Text] [Related]
15. Fungal infection and fever of unknown origin in neutropenic patients. Bodey GP Am J Med; 1986 May; 80(5C):112-9. PubMed ID: 3717185 [No Abstract] [Full Text] [Related]
16. Amphotericin B encapsulated in liposomes administered to cancer patients. Meunier F; Sculier JP; Coune A; Brassinne C; Heyman C; Laduron C; Collette N; Hollaert C; Bron D; Klastersky J Ann N Y Acad Sci; 1988; 544():598-610. PubMed ID: 2850759 [No Abstract] [Full Text] [Related]
17. Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial. Viscoli C; Castagnola E; Van Lint MT; Moroni C; Garaventa A; Rossi MR; Fanci R; Menichetti F; Caselli D; Giacchino M; Congiu M Eur J Cancer; 1996 May; 32A(5):814-20. PubMed ID: 9081359 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of amphotericin B in lipid emulsion for treating fungal septicemia in granulocytopenic patients. Macedo MC; Dulley FL; Ostronoff M; Machado CM; Zambon E; Matsumoto C; Dorlhiac-Llaccer P; Chamone DF Clin Infect Dis; 1994 Aug; 19(2):366-7. PubMed ID: 7986930 [No Abstract] [Full Text] [Related]
19. Candida and Aspergillus infections in immunocompromised patients: an overview. Saral R Rev Infect Dis; 1991; 13(3):487-92. PubMed ID: 1866554 [TBL] [Abstract][Full Text] [Related]
20. Successful treatment with liposomal amphotericin B in two patients with persisting fungemia. Sculier JP; Bron D; Coune A; Meunier F Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):903-7. PubMed ID: 2512139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]